EFTA00679054.pdf

From: <mwalkermdgginail.com> To: Jeffrey Epstein <jeevacationg,gmail.com> Subject: Fwd: Presentation Date: Thu, 27 Apr 2017 06:08:25 +0000 Attachments: Denali_Corp_Overview_April_20 I 4.pd f Begin forwarded message: From: Boris Nikolic Date: A ril 26. 2017 at 11:00:I I PM PDT To: Subjec : resen a ton Hi Bose and As we discussed, it would be great if Bill could meet Denali during his next visit to SF. He heard about it from several people. Denali's team is probably the best team in the biotech right now and has very promising pipeline in neurodegenerative diseases (ALS, PD, AD). The founder and a board member (and also ex-Chairman) is Marc Tessier-Lavigne a current President of Stanford (he was previously a President of Rockefeller University) The rest of team and the board is super impressive as well. The pipeline is very diverse — almost as a pharma's. This company is very well financed and is planning an IPO later this year. I am a large investor in this company. As expertise in neurology this will be a great first session for Bill for her. As Bose was introduced to the company during a JPM, it make sense that he takes a lead and you two work together for this learning session for Bill! Please let me know when you know some dates and I will provide you any necessary introduction and additional reading materials. Best Boris From: Steve Krognes Sent: Sunday, April 23, 2017 6:47 PM To: Boris Nikoli Subject: Presentation EFTA00679054 Dear Boris Great to catch up today. As agreed, please see enclosed a high level overview of Denali. Thanks a lot. Cheers, Steve EFTA00679055